Skip to main content
. 2019 Sep 30;25(23):10798–10813. doi: 10.1111/jcmm.14558

Table 2.

The effect of hUSCs on diabetic rats

Variable Normal Diabetes Diabetes + hUSCs‐Exo control Diabetes + hUSCs‐Exo miR‐16‐5p
Glu (mmol/L) 5.52 ± 0.47 25.45 ± 3.264 20.53 ± 2.17*, # 16.34 ± 1.33*, #
KW (g) 1.35 ± 0.15 2.58 ± 0.374 2.12 ± 0.27*, # 1.73 ± 0.16*, #
BW (g) 362.00 ± 15.35 242.54 ± 12.234 251.85 ± 14.244 253.45 ± 8.754
BUN (mmol/L) 8.24 ± 0.78 18.72 ± 1.254 15.35 ± 1.01*, # 12.01 ± 0.84*, #
Scr (μmol/L) 66.47 ± 5.72 99.27 ± 7.574 87.68 ± 6.54*, # 78.23 ± 3.87*, #
CCR (mmol/L) 1.05 ± 0.14 2.25 ± 0.254 1.70 ± 0.11*, # 1.41 ± 0.18*, #
Ucr (μmol/L) 89.46 ± 9.11 423.37 ± 45.484 245.82 ± 27.48*, # 287.37 ± 24.99*, #
Upro (mg/24 h) 6.47 ± 0.77 35.57 ± 4.374 14.85 ± 1.66*, # 19.37 ± 1.77*, #

Measurement data were expressed as mean ± standard deviation, data among multiple groups were analysed using one‐way analysis of variance, and the experiment was repeated three times.

Abbreviations: BUN, blood urea nitrogen; BW, body weight; CCR, creatinine clearance rate; Glu, blood glucose; hUSCs, human urine‐derived stem cells; KW, kidney weight; miR‐16‐5p, microRNA‐16‐5p; Scr, serum creatinine; Ucr, urine creatinine urine protein; Upro, urine protein.

*

P < .05 vs the normal group;

#

P < .05 vs the diabetes + hUSCs‐Exo control group.